Peptide that inhibits janus kinase

作者: Emmanuelle Fantino , Andrew Frederick Wilks , Julie Atkin

DOI:

关键词: Janus kinasePSLBiochemistryPeptideBiologyJAK activityKinase

摘要: The present invention provides a method of selecting or designing compound for the ability to regulate JAK activity. comprises assessing modulate interaction pseudo-substrate loop (PSL) with kinase like domain (KLD) JAK. In addition compounds which inhibit and methods treatment JAK-associated disease states.

参考文章(28)
A F Wilks, A Ziemiecki, A C Andres, R R Aston, A G Harpur, JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene. ,vol. 7, pp. 1347- 1353 ,(1992)
S. C. Kozma, S. M. Redmond, X. C. Fu, S. M. Saurer, B. Groner, N. E. Hynes, Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences. The EMBO Journal. ,vol. 7, pp. 147- 154 ,(1988) , 10.1002/J.1460-2075.1988.TB02794.X
Carl Ivar Branden, John Tooze, Introduction to protein structure ,(1991)
Arno F. Spatola, Peteris Romanovskis, James Jun Wen, Krzysztof Darlak, Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis ,(1995)
Roger Coleman, Susan G. Stuart, Human Jak2 kinase ,(1995)
Bruce A. Witthuhn, Ollie Silvennoinen, Frederick W. Quelle, James N. Ihle, Jak kinases and regulation of cytokine signal transduction ,(1994)
Millard Hurst Lambert, Valerie Gail Montana, Huaqiang Eric Xu, CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAME ,(2002)